BRSP Stock Analysis: Brightspire Capital | NYSE
REIT - Mortgage | NYSE, USA | Market Cap: 639m USD | 12M Return: 2.9% | US10949T1097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.53M
EPS Trend: -97.1%
Qual. Beats: -2
Rev. Trend: -93.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BrightSpire Capital, Inc. (BRSP) is a New York-based commercial real estate (CRE) credit REIT that originates, acquires, finances, and manages a diversified portfolio of CRE debt investments, including senior mortgage loans, mezzanine loans, preferred equity, net leased properties, and CRE debt securities, with operations in the United States and Norway. The company reports through three segments-Senior and Mezzanine Loans and Preferred Equity; Net Leased and Other Real Estate; and Corporate and Other-and also engages in money market activities and private equity fund investments. As a REIT, BrightSpire is required to distribute at least 90% of its taxable income to shareholders in order to avoid federal corporate income tax. The company was incorporated in 2017, IPOd in February 2018, and was renamed from Colony Credit Real Estate in June 2021.
CRE credit REITs such as BrightSpire typically focus on middle-market commercial real estate financing, a niche that sits between large bank lenders and direct private credit funds, and often concentrate on transitional or value-add assets. Net leased properties, one of the companys investment categories, are generally structured as long-term single-tenant arrangements where the tenant is responsible for most property-level operating expenses, providing more predictable cash flow compared to multi-tenant commercial properties.
- Office loan defaults weigh on CRE credit portfolio
- Floating-rate loans lift net interest margin higher
- Capital return program supports dividend amid CRE headwinds
| Net Income: -26.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.18 > 1.0 |
| NWC/Revenue: 2.87% < 20% (prev 744.5%; Δ -741.6% < -1%) |
| CFO/TA 0.02 > 3% & CFO 85.4m > Net Income -26.9m |
| Net Debt (2.60b) to EBITDA (76.1m): 34.16 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (126.7m) vs 12m ago -0.42% < -2% |
| Gross Margin: 43.24% > 18% (prev 52.42%; Δ -9.18% > 0.5%) |
| Asset Turnover: 9.23% > 50% (prev 9.71%; Δ -0.48% > 0%) |
| Interest Coverage Ratio: 0.34 > 6 (EBIT TTM 44.1m / Interest Expense TTM 128.2m) |
| A: 0.00 (Total Current Assets 221.1m - Total Current Liabilities 211.6m) / Total Assets 3.75b |
| B: -0.53 (Retained Earnings -1.98b / Total Assets 3.75b) |
| C: 0.01 (EBIT TTM 44.1m / Avg Total Assets 3.58b) |
| D: 0.30 (Book Value of Equity 863.0m / Total Liabilities 2.90b) |
| Altman-Z'' = -1.31 = CCC |
| DSRI: 0.10 (Receivables 51.4m/2.32b, Revenue 330.3m/331.0m) |
| GMI: 1.21 (GM 52.42% / 43.24%) |
| AQI: 4.08 (AQ_t 0.94 / AQ_t-1 0.23) |
| SGI: 1.00 (Revenue 330.3m / 331.0m) |
| TATA: -0.03 (NI -26.9m - CFO 85.4m) / TA 3.75b) |
| Beneish M = -1.75 (Cap -4..+1) = CCC |
As of August 12, 2026, the stock is trading at USD 4.90 with a total of 948,933 shares traded. Over the past week, the price has changed by -4.48%, over one month by -8.58%, over three months by -13.28% and over the past year by +2.85%.
Current recommended Stop Loss: 4.60 (which is 6.1% or 2 ATR below the current price).
Brightspire Capital has received a consensus analysts rating of 3.86. Therefore, it is recommended to buy BRSP.
- StrongBuy: 3
- Buy: 1
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 6.4 | 30.2% |
P/E Forward = 22.6757
P/S = 1.9165
P/B = 0.7345
Revenue TTM = 330.3m USD
EBIT TTM = 44.1m USD
EBITDA TTM = 76.1m USD
Long Term Debt = 2.55b USD (from longTermDebt, last quarter)
Short Term Debt = 211.6m USD (from shortTermDebt, last quarter)
Debt = 2.77b USD (from shortLongTermDebtTotal, last quarter) + Leases 12.9m
Net Debt = 2.60b USD (calculated: Debt 2.77b - CCE 169.7m)
Enterprise Value = 3.24b USD (638.9m + Debt 2.77b - CCE 169.7m)
Interest Coverage Ratio = 0.34 (Ebit TTM 44.1m / Interest Expense TTM 128.2m)
EV/FCF = 37.92x (Enterprise Value 3.24b / FCF TTM 85.4m)
FCF Yield = 2.64% (FCF TTM 85.4m / Enterprise Value 3.24b)
FCF Margin = 25.87% (FCF TTM 85.4m / Revenue TTM 330.3m)
Net Margin = -8.13% (Net Income TTM -26.9m / Revenue TTM 330.3m)
Gross Margin = 43.24% ((Revenue TTM 330.3m - Cost of Revenue TTM 187.5m) / Revenue TTM)
Gross Margin QoQ = 50.31% (prev 34.92%)
Tobins Q-Ratio = 0.86 (Enterprise Value 3.24b / Total Assets 3.75b)
Interest Expense / Debt = 4.63% (Interest Expense 128.2m / Debt 2.77b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 34.9m (EBIT 44.1m * (1 - 21.00%))
Current Ratio = 1.04 (Total Current Assets 221.1m / Total Current Liabilities 211.6m)
Debt / Equity = 3.21 (Debt 2.77b / totalStockholderEquity, last quarter 863.0m)
Debt / EBITDA = 34.16 (Net Debt 2.60b / EBITDA 76.1m)
Debt / FCF = 30.44 (Net Debt 2.60b / FCF TTM 85.4m)
Total Stockholder Equity = 923.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.75% (Net Income -26.9m / Total Assets 3.75b)
RoE = -2.91% (Net Income TTM -26.9m / Total Stockholder Equity 923.9m)
RoCE = 1.27% (EBIT 44.1m / Capital Employed (Equity 923.9m + L.T.Debt 2.55b))
RoIC = 0.93% (NOPAT 34.9m / Invested Capital 3.73b)
WACC = 4.58% (E(638.9m)/V(3.41b) * Re(8.56%) + D(2.77b)/V(3.41b) * Rd(4.63%) * (1-Tc(0.21)))
Discount Rate = 8.56% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -12.29 | Cagr: -0.22%
[DCF] Terminal Value 75.68% ; FCFF base≈84.8m ; Y1≈86.5m ; Y5≈94.4m
[DCF] Fair Price = N/A (negative equity: EV 1.46b - Net Debt 2.60b = -1.14b; debt exceeds intrinsic value)
EPS Correlation: -97.08 | EPS CAGR: -22.65% | SUE: -0.85 | # QB: -2
Revenue Correlation: -93.30 | Revenue CAGR: -8.09% | SUE: 0.45 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.14 | Chg30d=-5.62% | Revisions=-67% | Analysts=7
EPS current Year (2026-12-31): EPS=0.58 | Chg30d=-5.18% | Revisions=-67% | GrowthEPS=-9.8% | GrowthRev=+34.5%
EPS next Year (2027-12-31): EPS=0.65 | Chg30d=-6.73% | Revisions=-25% | GrowthEPS=+13.1% | GrowthRev=+0.2%
[Analyst] Revisions Ratio: -81% (up=0, down=13)